Exclusive | This Startup Is Using AI to Fight Off a Future AI Pandemic

In a wine bar near OpenAI’s office in San Francisco, biotech entrepreneurs Hannu Rajaniemi and Nikolai Eroshenko were worried—and excited.

Fast advances in artificial intelligence were threatening to make it possible for terrorists or rogue states to develop deadly new bioweapons. The pair brainstormed an idea they would later pitch to OpenAI: using AI to design remedies against AI-enabled bioweapons, and cure other scourges along the way, too.